J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

IMMEDIATE OPEN ACCESS ARTICLE
This Article
Free via Open Access: OA
Right arrow OA Free Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carter, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carter, M. J.
Agricola
Right arrow Articles by Carter, M. J.
J Med Microbiol 56 (2007), 875-883; DOI: 10.1099/jmm.0.47124-0
© 2007 Society for General Microbiology
ISSN 1473-5644

Review

A rationale for using steroids in the treatment of severe cases of H5N1 avian influenza

Marissa J. Carter

Strategic Solutions, Inc., 1143 Salsbury Ave, Cody, WY 82414, USA

Correspondence
Marissa J. Carter
strategicsolns{at}aol.com

Received 15 December 2006
Accepted 23 March 2007

Acute hypercytokinaemia represents an imbalance of pro-inflammatory and anti-inflammatory cytokines, and is believed to be responsible for the development of acute respiratory distress syndrome and multiple organ failure in severe cases of avian (H5N1) influenza. Although neuraminidase inhibitors are effective in treating avian influenza, especially if given within 48 h of infection, it is harder to prevent the resultant hypercytokinaemia from developing if the patient does not seek timely medical assistance. Steroids have been used for many decades in a wide variety of inflammatory conditions in which hypercytokinaemia plays a role, such as sepsis and viral infections, including severe acquired respiratory syndromes and avian influenza. However, to date, the results have been mixed. Part of the reason for the discrepancies might be the lack of understanding that low doses are required to prevent mortality in cases of adrenal insufficiency. Adrenal insufficiency, as defined in the sepsis/shock literature, is a plasma cortisol rise of at least 9 µg dl–1 following a 250 µg dose of adrenocorticotropin hormone (ACTH), or reaching a plasma cortisol concentration of >25 µg dl–1 following a 1–2 µg dose of ACTH. In addition, in the case of hypercytokinaemia induced by potent viruses, such as H5N1, systemic inflammation-induced, acquired glucocorticoid resistance is likely to be present. Adrenal insufficiency can be overcome, however, with prolonged (7–10 or more days) supraphysiological steroid treatment at a sufficiently high dose to address the excess activation of NF-{kappa}B, but low enough to avoid immune suppression. This is a much lower dose than has been typically used to treat avian influenza patients. Although steroids cannot be used as a monotherapy in the treatment of avian influenza, there might be a potential role for their use as an adjunct treatment to antiviral therapy if appropriate dosages can be determined. In this paper, likely mechanisms of adrenal insufficiency are discussed, drawing from a broad background of literature sources.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
T. Xu, J. Qiao, L. Zhao, G. He, K. Li, J. Wang, Y. Tian, and H. Wang
Effect of dexamethasone on acute respiratory distress syndrome induced by the H5N1 virus in mice
Eur. Respir. J., April 1, 2009; 33(4): 852 - 860.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B.-J. Zheng, K.-W. Chan, Y.-P. Lin, G.-Y. Zhao, C. Chan, H.-J. Zhang, H.-L. Chen, S. S. Y. Wong, S. K. P. Lau, P. C. Y. Woo, et al.
Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus
PNAS, June 10, 2008; 105(23): 8091 - 8096.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2007 Society for General Microbiology.